Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients

NCT02904031 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Elderly Metastatic Colorectal Cancer Patients

Interventions

DRUG: 5-fluorouracil
DRUG: oxaliplatin
DRUG: l-leucovorin
DRUG: panitumumab

Sponsor

Gruppo Oncologico del Nord-Ovest